drleonjimenez (Twitter) - ユーザ詳細

David León Jiménez (@drleonjimenez)

投稿
お気に入り
フォロー
フォロワー

投稿一覧（最新100件）

9 0 0 0 OA Efficacy and safety of insulin degludec U100 and insulin glargine U100 in combination with meal-time bolus insulin in hospitalized patients with type 2 diabetes: an open-label, randomized controlled study

Por fin los dos estudios de insulina ultrabasal in inpatients. versus Glargina 100U. @SEDiabetes @Diabetes_SEMI @Sociedad_SEMI @Sademi_MI @diabeteSEEN https://t.co/GxvsQ1L4B2 https://t.co/92xyd63O9A

2 0 0 0 OA Comparison of Canagliflozin, Dapagliflozin and Empagliflozin Added to Heart Failure Treatment in Decompensated Heart Failure Patients With Type 2 Diabetes Mellitus

@afcisnal @ConchiNavarroH @SantasEnrique Teneis este estudio comparativo también. De unos japoneses. https://t.co/lrzZZIvAAp Comparison of Canagliflozin, Dapagliflozin and Empagliflozin Added to Heart Failure Treatment in Decompensated Heart Failure Patients With Type 2 Diabetes Mellitus

4 0 0 0 OA Comparison of Canagliflozin, Dapagliflozin and Empagliflozin Added to Heart Failure Treatment in Decompensated Heart Failure Patients With Type 2 Diabetes Mellitus

Class efect or not? https://t.co/gAGXEGW587

3 0 0 0 OA Inter-organ Communication Pathway Manifested by Non-physiological Stress to the Kidney in Type II Diabetic Patients -Why Are Diabetic Patients Prone to Develop Heart Failure?

Inter-organ Communication Pathway Manifested by Non-physiological Stress to the Kidney in Type... - https://t.co/BU9WDNU5Dc #ScholarAlerts INTERESANTE PUNTO DE VISTA ICC-DM.. @Diabetes_SEMI @IcyfaSemi #ICyDM

David León Jiménez (@drleonjimenez)

投稿一覧（最新100件）

9 0 0 0 OA Efficacy and safety of insulin degludec U100 and insulin glargine U100 in combination with meal-time bolus insulin in hospitalized patients with type 2 diabetes: an open-label, randomized controlled study

2 0 0 0 OA Comparison of Canagliflozin, Dapagliflozin and Empagliflozin Added to Heart Failure Treatment in Decompensated Heart Failure Patients With Type 2 Diabetes Mellitus

4 0 0 0 OA Comparison of Canagliflozin, Dapagliflozin and Empagliflozin Added to Heart Failure Treatment in Decompensated Heart Failure Patients With Type 2 Diabetes Mellitus

3 0 0 0 OA Inter-organ Communication Pathway Manifested by Non-physiological Stress to the Kidney in Type II Diabetic Patients -Why Are Diabetic Patients Prone to Develop Heart Failure?

お気に入り一覧（最新100件）

フォロー（631ユーザ）の投稿一覧（直近7日間）

フォロワー（1043ユーザ）の投稿一覧（直近7日間）